Clinical Trial Update: Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity [Phase 2]

View source ↗

Summary

Phase 2 window study results evaluating nivolumab with or without ipilimumab in squamous cell carcinoma of the oral cavity were posted. The trial is associated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma of the Oral Cavity

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-07-31